DE2948186A1 - Antimicrobial higher n-alkyl-sulphonamide derivs. - prepd. by reaction of sulphonyl halide with higher alkylamine hydrochloride in the presence of aq. alkali hydroxide - Google Patents
Antimicrobial higher n-alkyl-sulphonamide derivs. - prepd. by reaction of sulphonyl halide with higher alkylamine hydrochloride in the presence of aq. alkali hydroxideInfo
- Publication number
- DE2948186A1 DE2948186A1 DE19792948186 DE2948186A DE2948186A1 DE 2948186 A1 DE2948186 A1 DE 2948186A1 DE 19792948186 DE19792948186 DE 19792948186 DE 2948186 A DE2948186 A DE 2948186A DE 2948186 A1 DE2948186 A1 DE 2948186A1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- alkyl
- sulfonamides
- antimicrobial
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 sulphonyl halide Chemical class 0.000 title claims description 39
- 230000000845 anti-microbial effect Effects 0.000 title claims description 10
- 150000008044 alkali metal hydroxides Chemical class 0.000 title claims description 8
- 229910001854 alkali hydroxide Inorganic materials 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 8
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims abstract description 3
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims description 32
- 150000003456 sulfonamides Chemical class 0.000 claims description 21
- 229940124530 sulfonamide Drugs 0.000 claims description 20
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 230000020477 pH reduction Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 229910005948 SO2Cl Inorganic materials 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 19
- 239000004599 antimicrobial Substances 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 239000008139 complexing agent Substances 0.000 abstract description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract description 4
- 239000000645 desinfectant Substances 0.000 abstract description 4
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 239000003755 preservative agent Substances 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 230000003385 bacteriostatic effect Effects 0.000 abstract description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract description 2
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 235000013365 dairy product Nutrition 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 239000004753 textile Substances 0.000 abstract description 2
- 235000010216 calcium carbonate Nutrition 0.000 abstract 1
- 238000009434 installation Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 15
- 244000052616 bacterial pathogen Species 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- VPTUPAVOBUEXMZ-UHFFFAOYSA-N (1-hydroxy-2-phosphonoethyl)phosphonic acid Chemical compound OP(=O)(O)C(O)CP(O)(O)=O VPTUPAVOBUEXMZ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- SLXBNXFAEASNHX-UHFFFAOYSA-N 2-(icosylamino)ethanol Chemical compound CCCCCCCCCCCCCCCCCCCCNCCO SLXBNXFAEASNHX-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- IZBZQUREHISXFJ-UHFFFAOYSA-N 2-[4-chloro-5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetic acid Chemical compound CC1=C(Cl)C(C(F)(F)F)=NN1CC(O)=O IZBZQUREHISXFJ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 235000007487 Calathea allouia Nutrition 0.000 description 1
- 244000278792 Calathea allouia Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
- A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
- A01N41/04—Sulfonic acids; Derivatives thereof
- A01N41/06—Sulfonic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Environmental Sciences (AREA)
- Epidemiology (AREA)
- Dentistry (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Birds (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Abstract
Description
"Neue Sul fonaniide, ihre Herstellung und ihre Verwendung"New sul fonaniides, their manufacture and their uses
als antimikrobielle Substanzen" Die Erfindung betrifft neue Sulfonamide der Formel I, in der R1 einen Alkylrest mit 1 bis 3 Kohlenstoffatomen, einen Phenylrest oder einen p-Tolylrest, R2 einen Alkylrest mit 10 bis 20 Kohlenstoffatomen und R3 Wasserstoff, einen Alkylrest mit 1 bis 3 Kohlenstoffatomen oder einen Hydroxyalkylrest mit 2 oder 3 Kohlenstoffatomen darstellt.as antimicrobial substances "The invention relates to new sulfonamides of the formula I, in which R1 is an alkyl group with 1 to 3 carbon atoms, a phenyl group or a p-tolyl group, R2 is an alkyl group with 10 to 20 carbon atoms and R3 is hydrogen, an alkyl group with 1 to 3 carbon atoms or a hydroxyalkyl group with 2 or 3 carbon atoms.
Die Erfindung betrifft weiterhin ein Verfahren zur Herstellung von Sulfonamiden der Formel I, bei dem man Aminhydrochloride der Formel II, in der R2 und R3 die für die Formel I angegebene Bedeutung haben, in wässriger Lösung mit Sulfonsäurechloriden der Formel III, R1 - S02C1 III in der R1 die für die Formel I angegebene Bedeutung hat, und Natriumhydroxid zu den Natriumsalzen der Sulfonamide der Formel II umsetzt, die Sulfonamide durch Ansäuren mit Mineralsäure ausfällt und anschließend abtrennt.The invention further relates to a process for the preparation of sulfonamides of the formula I, in which amine hydrochlorides of the formula II, in which R2 and R3 have the meaning given for the formula I, in aqueous solution with sulfonic acid chlorides of the formula III, R1 - S02C1 III in which R1 has the meaning given for the formula I and converts sodium hydroxide to the sodium salts of the sulfonamides of the formula II , the sulfonamides are precipitated by acidification with mineral acid and then separated off.
Die Erfindung betrifft schließlich die Verwendung der Verbindungen der Formel 1 als antimikrobielle Substanzen.Finally, the invention relates to the use of the compounds of formula 1 as antimicrobial substances.
Bei den Aminhydrochloriden der Formel II handelt es sich um bekannte Substanzen, die in einfacher Weise aus Aminen der Formel R2R)NH durch Umsetzung mit Salzsäure erhalten werden können. Als Amine der Formel R2R3NH kommen dabei unter anderen n-Decyl-, n-Undecyl-, n-Dodecyl-, n-Tetradecyl-, n-Hexadecyl-, n-Octadecyl-, n-Eicosyl-, n-Decylmethyl-, n-Decylethyl-, n-Dodecylmethyl-, n-Dodecylpropyl-, n-Tetradecylethyl-, n-Hexadecylmethyl-, n-Octadecylpropyl-, n-Eicosylmethyl-, n-Decylhydroxyethyl-, n-Dodecylhydroxyethyl, n-Dodeeylhydroxypropyl-, n-Hexadecylhydroxyethyl-, n-Octadecylhydroxypropyl- und n-Eicosylhydroxyethylamin in Betracht. Bevorzugt werden Aminhydrochloride von primären Aminen mit 10 bis 20 Kohlenstoffatomen und davon insbesondere solche mit 12 bis 14 Kohlenstoffatomcn als Ausgangsmaterial für die Herstellung der erfindungsgemäßen Sulfonamide eingesetzt.The amine hydrochlorides of the formula II are known Substances that can be obtained in a simple manner from amines of the formula R2R) NH by reaction can be obtained with hydrochloric acid. As amines of the formula R2R3NH come under other n-decyl, n-undecyl, n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, n-eicosyl, n-decylmethyl, n-decylethyl, n-dodecylmethyl, n-dodecylpropyl, n-tetradecylethyl, n-Hexadecylmethyl-, n-Octadecylpropyl-, n-Eicosylmethyl-, n-Decylhydroxyethyl-, n-dodecylhydroxyethyl, n-dodecylhydroxypropyl, n-hexadecylhydroxyethyl, n-octadecylhydroxypropyl and n-eicosylhydroxyethylamine. Amine hydrochlorides are preferred primary amines with 10 to 20 carbon atoms and of these in particular those with 12 to 14 carbon atoms as starting material for the preparation of the invention Sulfonamides used.
Als Sulfonsäurechloride der Formel II werden die Chloride der Methan-, Ethan-, Propan-, Benzol- und p-Toluolsulfonsäure eingesetzt.As sulfonic acid chlorides of the formula II, the Chlorides methane, ethane, propane, benzene and p-toluenesulfonic acid are used.
Die Umsetzung der Aminhydrochloride der Formel II mit den Sulfonsäurechloriden der Formel III und dem AlkalimetaLlhyoroxid wird zweckmäßigerweise in wässriger Lösung durchgeführt. Als Alkalimetallhydroxide kommen insbesondere Natrjum- und Kaliurrffiydroxid in Betracht. Die Reaktion wird im allgemeinen mit stöchiometrischen Mengen Aminhydrochlorid und Sulfonsäurechlorid durchgeführt. Man kann aber auch mit einem tjberschuB an Sulfonsäurechlorid arbeiten, sofern dies zur vollständigen Umsetzung des Aminhydrochlorids erforderlich erscheint. Das Sulfonsäurechlorid wird in diesem Fall gegenüber dem Aminhydrochlorid in einem Uberschuß von bis zu 30 Mol-% eingesetzt. Die Menge des Alkalimetallhydroxids ist in jedem Fall so zu bemessen, daß sie ausreicht, die im Aminhydrochlorid vorhandene und die bei der Reaktion mit dem Sulfonsäurechlorid entstehende Menge Chlorwasserstoff zu neutralisieren. Die Alkalimetallhydroxide werden dem Reaktionsgemisch in der Regel als wässrige, relativ konzentrierte Lösungen zugegen ben.The reaction of the amine hydrochlorides of the formula II with the sulfonic acid chlorides of the formula III and the alkali metal hydroxide is expediently in aqueous Solution carried out. The alkali metal hydroxides are in particular sodium and Potash hydroxide into consideration. The reaction is generally stoichiometric Amounts of amine hydrochloride and sulfonic acid chloride carried out. But you can too Work with an excess of sulfonic acid chloride, provided this is complete Implementation of the amine hydrochloride appears necessary. The sulfonic acid chloride is in this case compared to the amine hydrochloride in an excess of up to 30 mol% used. The amount of the alkali metal hydroxide is to be measured in each case in such a way that that it is sufficient, that present in the amine hydrochloride and that in the reaction with to neutralize the amount of hydrogen chloride produced by the sulfonic acid chloride. the Alkali metal hydroxides are generally used in the reaction mixture as aqueous, relative concentrated solutions present.
Bei der praktischen Durchführung des erfindungsgemäßen Herstellungsverfahrens ist es zweckmäßig, die gesamte Aminhydrochloridlösung vorzulegen und die vorgesehenen Mengen Sulfonsäurechlorid und Alkalimetallhydroxid unter Rühren langsam zuzugeben. Dabei ist darauf zu achten, daß die Reaktionsmischung stets schwach alkalisch reagiert. Man kann Alkalimetallhydroxid und Sulfonsäurechlorid mit etwa der gleichen Geschwindigkeit zugeben. Es ist jedoch auch möglich, die Base und das Säurechlorid abwechselnd in aliquoten Anteilen zuzugeben.In the practical implementation of the manufacturing process according to the invention it is advisable to submit the entire amine hydrochloride solution and the intended Slowly add amounts of sulfonic acid chloride and alkali metal hydroxide while stirring. Care must be taken that the reaction mixture always has a weakly alkaline reaction. One can alkali metal hydroxide and sulfonic acid chloride with about the same Admit speed. However, it is also possible to use the base and the acid chloride to be added alternately in aliquots.
Die Reaktion verläuft spontan und exotherm. Es ist deshalb angezeigt, die entstehende Reaktionswärme durch entsprechende Kühlung des Reaktionsgemisches abzurühren.The reaction is spontaneous and exothermic. It is therefore advisable the heat of reaction generated by appropriate cooling of the reaction mixture to stir off.
Aus den bei der Reaktion entstehenden Alkalisalzen der Sulfonamide. werden die gewünschten Verbindungen durch Ansäuern mit Mineralsäuren wie Salzsäure oder Schwefelsäure in Freiheit gesetzt und in an sich bekannter Weise abgetrennt, gewaschen und getrocknet.From the alkali salts of the sulfonamides formed during the reaction. the desired compounds are made by acidification with mineral acids such as hydrochloric acid or sulfuric acid released and separated in a known manner, washed and dried.
Bei den auf diese Weise erhaltenen Sulfonamiden der Formel I handelt es sich zumeist um wohldefiniert kristallisierende Substanzen; ein Teil fällt als zähe Flüssigkeit an. In der Regel können diese Substanzen ohne weitere Aufbereitung ihrer Verwendung als antimikrobielle Mittel zugeführt werden. Diese Substanzen sind in Wasser hinreichend löslich.The sulfonamides of the formula I obtained in this way are it is mostly a matter of well-defined crystallizing substances; part falls as thick liquid. As a rule, these substances can be processed without further processing their use as antimicrobial agents. These substances are Sufficiently soluble in water.
Gleichzeitig besitzen sie eine zufriedenstellende bis sehr gute Löslichkeit in organischen Lösungsmitteln. Ferner sind sie über einen weiten pH-Bereich stabil.At the same time, they have a satisfactory to very good solubility in organic solvents. They are also stable over a wide pH range.
Zur Verwendung in antimikrobiellen Mitteln können die Substanzen in flüssige, pastenförmige oder feste Zubereitungen eingearbeitet werden, wie z.B.For use in antimicrobial agents, the substances in liquid, pasty or solid preparations are incorporated, e.g.
wässrige Lösungen, Suspensionen, Emulsionen und Lösungen in organischen Lösungsmitteln. Derartige antimikrobielle Mittel können auf den verschiedensten Gebieten zum Einsatz gelangen, wie z.B. als Reinigungs-, Desinfektions- und Konservierungsmittel für Textilien, Fußböden, medizinische Instrumente, Krankenhauseinrichtungen, gewerbliche Betriebe, wie Molkereien, Brauereien und Wäschereien. Außerdem eignen sie sich zur Konservierung von technischen Produkten, die zu bakteriellem Befall und bakterieller Zersetzung neigen. Auf Grund ihrer guten physiologischen Verträglichkeit lassen sich die erfindungsgenäßen Substanzen mit Vorteil in Präparaten zur Körperpflege einsetzen, beispielsweise in Seifen, Shampoos und anderen KCIerreinigungsrnitteln, Deodorantien und sonstigen kosmetischen Präparaten zur Haut- und Körperpflege, die von Bakterien befallen werden können, w5e 'iautcrellcs, Lotionen, Schminken und Puder. In den antibakteriellen Mitteln werden die erfindungsgemäßen Substallzen in Mengen von 0,1 bis 10 Gew.-%, vorzugsweise 0,5 bis 5 Gew.-%, bezogen auf die gesamte antimikrobielle Zusammensetzung, eingesetzt. In Präparaten, die gegen Bakterien konserviert werden sollen, kommen die erfindungsgemäßen Substanzen in Mengen von 0,1 bis 2 Gew.-%, bezogen auf die Gesamtmenge des zu konservierenden Produktes, zur Anwendung.aqueous solutions, suspensions, emulsions and solutions in organic Solvents. Such antimicrobial agents can be in a variety of ways Areas are used, e.g. as cleaning agents, disinfectants and preservatives for textiles, floors, medical instruments, hospital facilities, commercial Establishments such as dairies, breweries and laundries. They are also suitable for Preservation of technical products that lead to bacterial and bacterial infestation Tend to decompose. Leave because of their good physiological tolerance The substances according to the invention are advantageously used in body care preparations use, for example in soaps, shampoos and other KCI cleaning agents, Deodorants and other cosmetic preparations for skin and body care that Can be attacked by bacteria, w5e 'iautcrellcs, lotions, and makeup Powder. The sub-stables according to the invention are used in the antibacterial agents in amounts of 0.1 to 10 wt .-%, preferably 0.5 to 5 wt .-%, based on the entire antimicrobial composition used. In preparations against bacteria are to be preserved, the substances according to the invention come in amounts of 0.1 to 2% by weight, based on the total amount of the product to be preserved, to use.
In Präparationen, in denen ein Zusatz von Komplexbildnern angebracht ist, können die erfindungsgemäßen Sulfonamide der Formel I auch mit Komplexbildnern kombiniert werden, die im Hamshire-Test ein größeres Calciumcarbonat-Bindevermögen als 230 mg Je g Komplexbildner aufweisen. Hierdurch ist gegebenenfalls eine weitere Wirkungssteigerung möglich.In preparations in which the addition of complexing agents is appropriate the sulfonamides of the formula I according to the invention can also be used with complexing agents which in the Hamshire test have a greater calcium carbonate binding capacity than 230 mg per g of complexing agent. This may result in a further Increased effectiveness possible.
Die erfindungsgemäßen Substanzen zeichnen sich durch eine sehr gute bakteriostatische und bakterizide Wirksamkeit aus, die ihren Einsatz besonders auf solchen Gebieten gestattet, bei denen es nicht nur auf die Hemmung des bakteriellen Wachstums, sondern auf eine Abtötung der Bakterien in technisch annehmbaren Zeiträumen unter Verwendung niederer Konzentrationen ankommt.The substances according to the invention are distinguished by one very good bacteriostatic and bactericidal effectiveness, which makes their use particularly Permitted in areas where it is not only due to the inhibition of the bacterial Growth, but rather on killing the bacteria in technically acceptable periods of time using lower concentrations.
Die nachfolgenden Beispiele sollen den Gegenstand der Erfindung näher erläutern, ohne ihn jedoch hierauf zu beschränken.The following examples are intended to illustrate the subject matter of the invention in greater detail explain without, however, restricting it to this.
Beispiele I. Herstellung der Sulfonamide der Formel I Beispiel 1 Zu einer Lösung von 33,3 g (0,15 Mol) Dodecylaminhydrochlorid in 300 ml Wasser wurden unter Rühren und Eiskühlung aus 2 Tropftrichtern gleichzeitig 60 Inl (0,) Ilol) 5 n Natriumhydroxidlösung und 17,1 g (0,15 Mol) Methansulfonsäurechlorid zugetropf. Dabei wurde die Zufuhr so geregelt, daß die Lösung stets schwach alkalisch reagierte. Nach beendeter Zugabe wurde 1 Srunde lang bei Raumtemperatur weitergerührt.Examples I. Preparation of the sulfonamides of the formula I Example 1 To a solution of 33.3 g (0.15 mol) of dodecylamine hydrochloride in 300 ml of water while stirring and ice cooling from 2 dropping funnels at the same time 60 Inl (0,) Ilol) 5 N sodium hydroxide solution and 17.1 g (0.15 mol) methanesulphonic acid chloride were added dropwise. The feed was regulated so that the solution always reacted weakly alkaline. After the addition had ended, stirring was continued for 1 hour at room temperature.
Die Lösung wurde dann mit konzentrierter Salzsäure angesäuert und eingeengt. Nach dem Abkühlen wurde das ausgefallene Produkt abfiltriert und aus Aceton umkristallisiert. Dabei wurden 56,6 g weiße Kristalle (92,6 ß d. Th.) vom Smp. 73° C erhalten.The solution was then acidified with concentrated hydrochloric acid and constricted. After cooling, the precipitated product was filtered off and removed Recrystallized acetone. 56.6 g of white crystals (92.6 ß d. Th.) Were from M.p. 73 ° C.
Beispiel 2 In Analogie zu Beispiel 1 wurde eine Reihe von weiteren Sulfonamiden der Formel I aus entsprechenden Aminoalkanolen hergestellt. Alle erhaltenen Substanzen sind in der Tabelle I wiedergegeben.Example 2 In analogy to Example 1, a number of further sulfonamides of the formula I made from corresponding aminoalkanols. All the substances obtained are shown in Table I.
Tabelle 1
Danach wurde festgestellt, weiche dem Nährmedium zugefügte Wirkstoffkonzentration das Wc chstum der Keime gerade noch gehemmt hatte. Der auf diese Weise gefundene ert wurde als Hemmkonzentration bezeichnet.It was then determined which concentration of active substance added to the nutrient medium had just inhibited the growth of the germs. The one found this way ert was referred to as the inhibitory concentration.
Folgende Wirkstoffkonzentrationen in ppm wurden getestet: 1 000, 750, 500, 250, 100, 50, 10 Die für die Substanzen A bis M wurden die in der nachstehenden Tabelle II aufgeführten Hemmkonzentrationen ermittelt.The following active ingredient concentrations in ppm were tested: 1,000, 750, 500, 250, 100, 50, 10 Those for Substances A to M became those in the following Inhibitory concentrations listed in Table II were determined.
Tabelle II Hemmkonzentration der Substanzen A bis M in ppm
Die zu prüfenden Substanzen wurden zunächst in wenig Alkohol gelöst. Aus den ethanolischen Lösungen wurden durch Verdünnen mit entionisiserter Wasser Testlösungen hergestellt, die 1G00 pprti, 750 ppm, 500 ppm, 250 ppm und 100 ppm Wirkstoff und maximal 1 Gew.-% Ethanol enthielten. Den Richtlinien entsprechend wurden bei Raumtemperatur Jeweils 0,1 ml Testkeimsuspension in Reagenzgläser pipettiert. Hierzu wurden jeweils 10 ml der oben beschriebenen Testlösungen gegeben. Nach Einwirkkunsszeiten von 2 1/2, 5, 10, 20, 40, 60 und 120 Minuten wurde den Reagenzläsern mit Hilfe einer Öse ein Tropfen Material entnommen und in iO ml Nährlösung, die 3 % Tween 80 und 0,3 % Lecithin als Enthemmer enthielt, überrimpft. Das Nährmedium bestand bei den Bakterien aus 1 gew.-%iger Standard-I-Bouillon (Merck), bei Candida albicans aus 1 gew.-%iger Bierwürzelösung.The substances to be tested were first dissolved in a little alcohol. The ethanolic solutions were diluted with deionized water Test solutions made that contain 1G00 pprti, 750 ppm, 500 ppm, 250 ppm, and 100 ppm Contained active ingredient and a maximum of 1% by weight of ethanol. According to the guidelines 0.1 ml of test germ suspension was pipetted into test tubes at room temperature. To this end, 10 ml of the test solutions described above were added in each case. After exposure times of 2 1/2, 5, 10, 20, 40, 60 and 120 minutes was added to the test tubes using a A drop of material is removed from the eyelet and placed in iO ml of nutrient solution containing 3% Tween 80 and 0.3% lecithin contained as a disinhibitor. The nutrient medium consisted of the Bacteria from 1% by weight standard I broth (Merck), in Candida albicans 1% by weight beer wort solution.
Die mit Bakterien beimpftem Proben wurden bei 370 C, die mit Canida albicans beimpften Proben bei 300 C bebrütet. Nach frühestens 5 Tagen wurden die Kulturen makroskopisch auf Wachstum beurteilt und auf diesem Weg die Abtötungszeiten ermittelt, die in der nachstehenden Tabelle III wiedergegeben sind.The samples inoculated with bacteria were stored at 370 C, those with Canida albicans inoculated samples incubated at 300 ° C. After 5 days at the earliest, the Cultures assessed macroscopically for growth and in this way the killing times determined, which are given in Table III below.
Tabelle III Abtötungszeiten bei Konzentrationen von 1000, 750, 500,
250 und 100 ppm in Minuten
Die Hautverträglichkeit wurde zunächst durch einmaliges Auftragen einer kleinen Substanzmenge an haarlosen M;usen getestet.1-, 5- und 25-gewichtsprozentige Lösungen in Ethanol ergaben nach 24 Stunden keinen Befund. Wurde eine 5-gewichtsprozentige ethanolische Lösung täglich zweimal aufgetragen, so waren nach 10 Tagen mäßige Hautreizungen zu beobachten.The skin tolerance was initially determined by a single application a small amount of substance tested on hairless mice. 1, 5 and 25 percent by weight Solutions in ethanol gave no result after 24 hours. Became a 5 weight percent When ethanolic solution was applied twice a day, there was moderate skin irritation after 10 days to observe.
Der Burkhard-Test an Menschen, mit einer 1-gewichts prozentigen ethanolischen Lösung an 5 Probanden durchgefUhrt, ergab keinen Befund.The Burkhard test on humans, with a 1 percent by weight ethanolic Solution carried out on 5 test persons gave no result.
IV. Verwendung der Sulfonamide der Formel I als antimikrobielle Substanzen Nachstehend werden einige Beispiele für die Verwendung der erfindungsgemäßen Sulfonamide als antimikrobielle Mittel angegeben (GT = Gewtchtsteile).IV. Use of the sulfonamides of the formula I as antimicrobial substances Below are some examples of the use of the sulfonamides of the invention indicated as antimicrobial agents (GT = parts by weight).
1. Desinfizierende Handwaschpaste 52 GT Natriumlaurylsulfat (ca. 35 Gew.-% Waschaktivsubstanz) 3 GT Kokosfetsäuremonoethanolamid 43 GT Bimsstein, fein gemahlen 2 GT Substanz A An Stelle der Substanz A können mit gleich gutem Erfolg die Produkte G und M eingesetzt werden.1. Disinfecting hand washing paste 52 GT sodium lauryl sulfate (approx. 35 Wt .-% washing active substance) 3 pbw coconut fatty acid monoethanolamide 43 pbw pumice stone, fine ground 2 parts by weight of substance A instead of substance A can be used with equally good success products G and M are used.
2. Antimikrobielle Seife Bei der üblichen Herstellung einer Toiletteseife aus einem Gemisch aus 60 Gew.-% Kokosfettsäure-Natriumsalz und 40 Gew.-% Talgfettsäure-Natriumsalz arbeitet man in der Schneckenpresse zusammen mit dem Farbstoff und dem Parfüm solche Mengen der Substanz F ein, daß die fertige Seile 1 Gew.-» davon enthält. Die antimikrobielle Wirkung wird noch gesteigert, wenn man zusätzlich so viel Komplexbildner (Nitrilotriacetat, Ethylendiamintetraacetat oder 1-Hydroxyethandiphosphonat) einarbeitet, daß (leren Anteil in der Seife 8 Gew.-% ausmacht.2. Antimicrobial soap In the usual manufacture of a toilet soap from a mixture of 60% by weight coconut fatty acid sodium salt and 40% by weight tallow fatty acid sodium salt one works in the screw press together with the dye and the perfume such Amounts of substance F that the finished rope contains 1% by weight thereof. The antimicrobial Effect is increased if you also use so much complexing agent (nitrilotriacetate, Ethylenediamine tetraacetate or 1-hydroxyethanediphosphonate) incorporates that (leren The proportion in the soap is 8% by weight.
An Stelle der Substanz F können die Produkte C, I und L mit vergleichbarem Erfolg eingesetzt werden.Instead of the substance F, the products C, I and L can be used with comparable Success can be used.
3. Schaumbad 70 GT Natriumaurylethersulfat (27 - 28 Gew.-% Waschativsubstanz) 5 GT Kokosrettsäurediethanolamid 0,5 GT Substanz B 24,5 GT Wasser An Stelle der Substanz B können auch die Verbindungen E, H und K in die Zusammensetzung eingearbeitet werden.3. Foam bath 70 parts by weight sodium auryl ether sulfate (27 - 28% by weight detergent substance) 5 pbw coconut acid diethanolamide 0.5 pbw substance B 24.5 pbw water instead of Substance B can also incorporate the compounds E, H and K into the composition will.
4. Deodorant - Spray 10 GT Octyldodecanol 1 GT Parfüm 2 GT Substanz C 87 GT Ethanol 100 GT Treibgas In dieser Zusammensetzung kann die Substanz C durch die Produkte D, H und J ersetzt werden.4. Deodorant spray 10 parts by weight octyldodecanol 1 part by weight perfume 2 parts by weight substance C 87 pbw ethanol 100 pbw propellant gas In this composition can Substance C can be replaced by products D, H and J.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792948186 DE2948186A1 (en) | 1979-11-30 | 1979-11-30 | Antimicrobial higher n-alkyl-sulphonamide derivs. - prepd. by reaction of sulphonyl halide with higher alkylamine hydrochloride in the presence of aq. alkali hydroxide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792948186 DE2948186A1 (en) | 1979-11-30 | 1979-11-30 | Antimicrobial higher n-alkyl-sulphonamide derivs. - prepd. by reaction of sulphonyl halide with higher alkylamine hydrochloride in the presence of aq. alkali hydroxide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2948186A1 true DE2948186A1 (en) | 1981-07-23 |
Family
ID=6087230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19792948186 Withdrawn DE2948186A1 (en) | 1979-11-30 | 1979-11-30 | Antimicrobial higher n-alkyl-sulphonamide derivs. - prepd. by reaction of sulphonyl halide with higher alkylamine hydrochloride in the presence of aq. alkali hydroxide |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE2948186A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006081994A3 (en) * | 2005-02-05 | 2007-03-22 | Lohmann Therapie Syst Lts | Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE866940C (en) * | 1938-05-06 | 1953-02-12 | Hydrierwerke A G Deutsche | Process for the preparation of p-aminobenzenesulfimides |
| DE890958C (en) * | 1940-06-11 | 1953-09-24 | Bayer Ag | Process for the preparation of sulfonamide compounds |
| DE2151491A1 (en) * | 1970-10-15 | 1972-04-20 | Givaudan & Cie Sa | Hydroxyhalobenzenesulfonanilides |
-
1979
- 1979-11-30 DE DE19792948186 patent/DE2948186A1/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE866940C (en) * | 1938-05-06 | 1953-02-12 | Hydrierwerke A G Deutsche | Process for the preparation of p-aminobenzenesulfimides |
| DE890958C (en) * | 1940-06-11 | 1953-09-24 | Bayer Ag | Process for the preparation of sulfonamide compounds |
| DE2151491A1 (en) * | 1970-10-15 | 1972-04-20 | Givaudan & Cie Sa | Hydroxyhalobenzenesulfonanilides |
Non-Patent Citations (5)
| Title |
|---|
| C.A. 56, 1962, 8638 i * |
| C.A. 62, 1965, 11023 c * |
| C.A. 72, 1970, 33179 e * |
| C.A. 84, 1976, 76686 h * |
| Ehrhart, G., RUSCHIG, H.: Arzneimittel, Bd.4, 1972, S.87, 88, 107, 108 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006081994A3 (en) * | 2005-02-05 | 2007-03-22 | Lohmann Therapie Syst Lts | Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma |
| JP2008528647A (en) * | 2005-02-05 | 2008-07-31 | エルテーエス ローマン テラピー−ジステーメ アーゲー | Isolation of N-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives and use of N-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostatic hyperplasia and / or prostate malignancy |
| DE102005005397B4 (en) * | 2005-02-05 | 2008-08-21 | Lts Lohmann Therapie-Systeme Ag | Isolation of N-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of N-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostatic hyperplasia and / or prostate carcinoma |
| US7700654B2 (en) | 2005-02-05 | 2010-04-20 | Lts Lohmann Therapie-Systeme Ag | Isolation of N-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of N-butylbenzenesulfonamide and benzenesulfonamide derivatives for treating benign prostatic hyperplasia and/or prostate carcinoma |
| CN101111240B (en) * | 2005-02-05 | 2011-09-21 | Lts罗曼治疗方法有限公司 | Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperp |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2125893C3 (en) | Preparations for combating microorganisms and their use | |
| DE2808943A1 (en) | NEW GUANIDINIUM SALTS, THE PROCEDURE FOR THEIR PRODUCTION AND MICROBICIDAL PREPARATIONS CONTAINING THESE COMPOUNDS | |
| DE2530243C2 (en) | Use of N-substituted aminoalkanols as antimicrobial agents | |
| DE2657193A1 (en) | NEW PRODUCTS FOR PRODUCTS OF EPSILON -CAPROLACTAM AND BETA-HYDROXYALKYLAMINES, AND THEIR AETHYLENE OXIDE ADDUCTS, THEIR PRODUCTION AND USE AS ANTIMICROBIAL AGENTS | |
| DE2218417A1 (en) | USE OF SUBSTITUTED OXAZOLIDINS AS ANTIMICROBIAL ACTIVE INGREDIENTS | |
| DE2948186A1 (en) | Antimicrobial higher n-alkyl-sulphonamide derivs. - prepd. by reaction of sulphonyl halide with higher alkylamine hydrochloride in the presence of aq. alkali hydroxide | |
| CH515875A (en) | Bis-phenoxyphenyl esters antibacterial | |
| DE2531343A1 (en) | Antimicrobial compsns. contg. substd. benzoyl phenyl guanidines - prepd. from opt. substd. benzoyl cyanamides and substd. anilines | |
| DE2833135A1 (en) | Substd. oligo amidine derivs. used as microbistatic - for use as preserving agent in cosmetic and antimicrobial prods. such as lotions, soaps and deodorants | |
| DE3148047C2 (en) | ||
| DE2347932B2 (en) | Adducts of epoxy compounds with reaction products of E-caprolactam with N-alkylalkanediamines, their production and use as antimicrobial agents | |
| DE2407289C2 (en) | 5-Bromo-5-nitro-2-alkyl-1,3-dioxanes, processes for their preparation and antimicrobial agents containing these compounds | |
| EP0437900B1 (en) | Disinfectant solution with improved germicidal action | |
| EP0005806B1 (en) | Use of aminohydroxystearic acid amides | |
| DE3147990C2 (en) | ||
| EP0029974A1 (en) | Sulphone amides, their preparation and their use as antimicrobial substances | |
| DE2744353A1 (en) | HYDANTOIN DERIVATIVES, THE PROCESS FOR THEIR PRODUCTION AND THEIR USE | |
| AT267049B (en) | Process for the manufacture of a skin disinfectant | |
| DE1668195C3 (en) | Bromo-nitroalkyl-N-phenylcarbamates and antimicrobial agents containing them | |
| DE2516922C3 (en) | Disinfectants | |
| DE1793083A1 (en) | New substituted diphenyl esters of mono- and dithiocarbonic acids, processes for their production and the use of these esters for combating microorganisms, in particular bacteria | |
| DE1903864A1 (en) | Antimicrobial preparation | |
| AT285828B (en) | Bactericidal detergents and dishwashing agents | |
| DE1912496A1 (en) | Alpha- (2-hydroxy, 3,5,6-trichloro-) phenylglycolic acid | |
| DE2456874A1 (en) | Antimicrobial 2-oxo-1,2,3-oxathiazolidines - contg a long chain aliph, gp., are effective in low concns |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8125 | Change of the main classification |
Ipc: A01N 41/06 |
|
| 8130 | Withdrawal |